Literature DB >> 24862359

Infants under 6 months with bronchiolitis are most likely to need major medical interventions in the 5 days after onset.

H Pruikkonen1, M Uhari, T Dunder, T Pokka, M Renko.   

Abstract

AIM: This study examined the need for, and timing of, major medical interventions (MMIs) in infants under 6 months of age with bronchiolitis.
METHODS: We reviewed the medical records of 353 children who visited our emergency department with bronchiolitis. MMI was defined as the need for any of the following interventions during admission: supplementary oxygen, intravenous fluids, intravenous antibiotics or admission to the intensive care unit.
RESULTS: Altogether 19% of the 353 patients required a MMI and 3% had apnoea. The patients with apnoea were all under 2 months of age, and 90% had a respiratory syncytial virus (RSV) infection and 40% had been born prematurely. The risk of needing a MMI continued for up to 5 days after disease onset. A positive RSV test predicted a MMI with an odds ratio (OR) of 11.5 (95% CI 2.6-50.5), and a fever of over 38°C predicted a MMI with an OR of 3.5 (95% CI 1.4-8.8). Each 1% increase in the initial oxygen saturation value was associated with a decreased risk of MMI (OR 0.7, 95% CI 0.6-0.8).
CONCLUSION: Infants under 6 months of age with bronchiolitis were most likely to need MMIs in the first 5 days after disease onset. ©2014 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Bronchiolitis; Dyspnoea; Hospitalisation; Respiratory syncytial virus infection; Wheezing

Mesh:

Year:  2014        PMID: 24862359     DOI: 10.1111/apa.12704

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

1.  Families' costs form a considerable part of total costs in bronchiolitis care.

Authors:  Emilia Mäntynen; Sauli Palmu; Paula Heikkilä
Journal:  Health Sci Rep       Date:  2022-04-26

Review 2.  The cost-effectiveness of hypertonic saline inhalations for infant bronchiolitis: a decision analysis.

Authors:  Paula Heikkilä; Minna Mecklin; Matti Korppi
Journal:  World J Pediatr       Date:  2018-02-23       Impact factor: 2.764

Review 3.  Pneumococcal septic shock after neonatal respiratory syncytial virus bronchiolitis: A case report and literature review.

Authors:  Antonella Di Caprio; Elena Coccolini; Paola Zagni; Eleonora Vaccina; Laura Lucaccioni; Licia Lugli; Lorenzo Iughetti; Alberto Berardi
Journal:  Acta Biomed       Date:  2021-04-30

4.  TLR5 rs5744174 gene polymorphism is associated with the virus etiology of infant bronchiolitis but not with post-bronchiolitis asthma.

Authors:  Sari Törmänen; Johanna Teräsjärvi; Eero Lauhkonen; Merja Helminen; Petri Koponen; Matti Korppi; Kirsi Nuolivirta; Qiushui He
Journal:  Health Sci Rep       Date:  2018-05-24

Review 5.  Helium-oxygen in bronchiolitis-A systematic review and meta-analysis.

Authors:  Ilari Kuitunen; Panu Kiviranta; Ulla Sankilampi; Heli Salmi; Marjo Renko
Journal:  Pediatr Pulmonol       Date:  2022-03-23

6.  Gene Polymorphism of Toll-Like Receptors and Lung Function at Five to Seven Years of Age after Infant Bronchiolitis.

Authors:  Eero Lauhkonen; Petri Koponen; Juho Vuononvirta; Johanna Teräsjärvi; Kirsi Nuolivirta; Jyri O Toikka; Merja Helminen; Qiushui He; Matti Korppi
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

Review 7.  Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease.

Authors:  Josep Figueras-Aloy; Paolo Manzoni; Bosco Paes; Eric A F Simões; Louis Bont; Paul A Checchia; Brigitte Fauroux; Xavier Carbonell-Estrany
Journal:  Infect Dis Ther       Date:  2016-09-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.